Strous G J, Du Maine A, Zijderhand-Bleekemolen J E, Slot J W, Schwartz A L
J Cell Biol. 1985 Aug;101(2):531-9. doi: 10.1083/jcb.101.2.531.
We studied the intracellular transport of secretory and membrane proteins in the human hepatoma cell line HepG-2 infected with vesicular stomatitis virus. Cells were pulse-labeled in the presence of [35S]methionine and chased in the presence of the lysosomotropic agent primaquine. At a concentration of 0.3 mM primaquine effectively inhibited the secretion of albumin and, to a lesser extent, that of orosomucoid and transferrin. The drug also prevented the budding of virus particles at the cell surface. The intracellular transport to the Golgi complex of the membrane protein VSV-G was not affected by primaquine as it acquires resistance to endo-beta-N-acetylglucosaminidase H at the same rate as in control cells. Addition of primaquine at various times after the initiation of the chase period indicates that the effect of primaquine occurs just before secretion. In confirmation of the biochemical data, immunocytochemical localization of albumin in cells treated with NH4Cl demonstrated that albumin accumulated in vesicles at the trans side of the Golgi complex. The effect of primaquine on secretion was also compared with its effect on receptor recycling. The dose-response characteristics of the effect of primaquine on receptor recycling are identical to those of the effects on protein secretion and virus budding. These results indicate that both processes involve the same transport mechanism, and/or that they occur via at least one identical intracellular compartment.
我们研究了感染水疱性口炎病毒的人肝癌细胞系HepG-2中分泌蛋白和膜蛋白的细胞内运输。细胞在[35S]甲硫氨酸存在下进行脉冲标记,并在溶酶体促渗剂伯氨喹存在下进行追踪。在浓度为0.3 mM时,伯氨喹有效地抑制了白蛋白的分泌,对类粘蛋白和转铁蛋白的分泌抑制作用较小。该药物还阻止了病毒颗粒在细胞表面的出芽。膜蛋白VSV-G向高尔基体复合体的细胞内运输不受伯氨喹的影响,因为它获得对内切β-N-乙酰葡糖胺酶H的抗性的速率与对照细胞相同。在追踪期开始后的不同时间添加伯氨喹表明,伯氨喹的作用发生在分泌之前。作为生化数据的佐证,用NH4Cl处理的细胞中白蛋白的免疫细胞化学定位表明,白蛋白积聚在高尔基体复合体反面的囊泡中。还比较了伯氨喹对分泌的作用与其对受体循环的作用。伯氨喹对受体循环作用的剂量反应特征与对蛋白质分泌和病毒出芽的作用相同。这些结果表明,这两个过程涉及相同的运输机制,和/或它们至少通过一个相同的细胞内区室发生。